Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2022
19/4 12:30
Company Announcement Net sales of DARZALEX ® in the first quarter of 2022 totaled USD 1,856 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. COPENHAGEN , Denmark; April 1 9 , 20 2 2 – Genmab A/S ( Nasdaq : GMAB) announced today that worldwide net trade sales of...